Advisor Group’s Microbot Medical MBOT Stock Holding History

Advisor Group’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$2K	Buy	202 +200	+10,000%	+$1.17K	﹤0.01%	4997
2019 Q3	$0	Hold	2	–	–	﹤0.01%	5357
2019 Q2	$0	Hold	2	–	–	﹤0.01%	5305
2019 Q1	$0	Sell	2 -467	-100%	-$3.63K	﹤0.01%	5274
2018 Q4	$1K	Hold	469	–	–	﹤0.01%	4981
2018 Q3	$4K	Sell	469 -165	-26%	-$1.42K	﹤0.01%	4665
2018 Q2	$7K	Sell	634 -1,100	-63%	-$13.4K	﹤0.01%	4251
2018 Q1	$18K	Buy	1,734 +1,733	+173,300%	+$23.4K	﹤0.01%	3740
2017 Q4	$0	Hold	1	–	–	﹤0.01%	5021
2017 Q3	$0	Hold	1	–	–	﹤0.01%	4911
2017 Q2	$0	Hold	1	–	–	﹤0.01%	4857
2017 Q1	$0	Buy	+1	New	+$88	﹤0.01%	4751
2016 Q4	–	Hold	0	–	–	–	4574
2016 Q3	–	Hold	0	–	–	–	4553
2016 Q2	–	Hold	0	–	–	–	4451

Other funds holding MBOT

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Advisor Group's MBOT Position: Q4 2019 in Review

Advisor Group increased its Microbot Medical (MBOT) stake by 10,000% in Q4 2019, buying an estimated $1.17K and bringing the position to 202 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #4997.

Advisor Group first reported a position in MBOT in Q1 2017 and has held it in 12 quarters since. The position peaked at $18K in Q1 2018. 28 funds tracked by Wall St. Rank hold MBOT as of Q4 2019.

Advisor Group held 202 shares of Microbot Medical worth $2K as of Q4 2019.
Advisor Group bought 200 Microbot Medical shares in Q4 2019, an estimated $1.17K.
Microbot Medical made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4997 holding.
Advisor Group first reported a position in Microbot Medical in Q1 2017 and has held it in 12 quarters since.
Advisor Group's Microbot Medical position peaked at $18K in Q1 2018.
28 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.